Measurement of FeNO clinical trials

Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer

This study looks at whether a simple breath test can help predict how well immunotherapy will work for people with an advanced type of lung cancer. We're checking breathe samples before and after treatment.